Evidence map›Paper›PMID 30617495›Full record

ArticleEuropean radiology2019

Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.

Ming Fan, Peng Zhang, Yue Wang, Weijun Peng, Shiwei Wang, Xin Gao, Maosheng Xu, Lihua Li

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Value for combination of TZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Ming FanInstitute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi University, Hangzhou, China.
Peng ZhangInstitute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi University, Hangzhou, China.
Yue WangDepartment of Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, Arlington, VA, 22203, USA.
Weijun PengDepartment of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Shiwei WangDepartment of Radiology, First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Xin GaoComputational Bioscience Research Center (CBRC), Computer, Electrical and Mathematical Sciences and Engineering Division (CEMSE), King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi Arabia.
Maosheng XuDepartment of Radiology, First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China. 1243454330@qq.com.
Lihua LiInstitute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi University, Hangzhou, China. lilh@hdu.edu.cn.
Hangzhou Dianzi University · CNZhejiang Chinese Medical University · CNFudan University Shanghai Cancer Center · CNKing Abdullah University of Science and Technology · SAVirginia Tech · US

Funding

King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) URF/1/3450-01National Natural Science Foundation of China 61271063National Natural Science Foundation of China 61401131National Natural Science Foundation of China 61731008National Natural Science Foundation of China (CN) 61871428Natural Science Foundation of Zhejiang Province of China LZ15F010001
6 · The paper itself

Abstract

objectivesThis study aimed to predict the molecular subtypes of breast cancer via intratumoural and peritumoural radiomic analysis with subregion identification based on the decomposition of contrast-enhanced magnetic resonance imaging (DCE-MRI).

methodsThe study included 211 women with histopathologically confirmed breast cancer. We utilised a completely unsupervised convex analysis of mixtures (CAM) method by unmixing dynamic imaging series from heterogeneous tissues. Each tumour and the surrounding parenchyma were thus decomposed into multiple subregions, representing different vascular characterisations, from which radiomic features were extracted. A random forest model was trained and tested using a leave-one-out cross-validation (LOOCV) method to predict breast cancer subtypes. The predictive models from tumoural and peritumoural subregions were fused for classification.

resultsTumour and peritumour DCE-MR images were decomposed into three compartments, representing plasma input, fast-flow kinetics, and slow-flow kinetics. The tumour subregion related to fast-flow kinetics showed the best performance among the subregions for differentiating between patients with four molecular subtypes (area under the receiver operating characteristic curve (AUC) = 0.832), exhibiting an AUC value significantly (p < 0.0001) higher than that obtained with the entire tumour (AUC = 0.719). When the tumour- and parenchyma-based predictive models were fused, the performance, measured as the AUC, increased to 0.897; this value was significantly higher than that obtained with other tumour partition methods.

conclusionsRadiomic analysis of intratumoural and peritumoural heterogeneity based on the decomposition of image time-series signals has the potential to more accurately identify tumour kinetic features and serve as a valuable clinical marker to enhance the prediction of breast cancer subtypes. KEY POINTS: • Decomposition of image time-series signals has the potential to more accurately identify tumour kinetic features. • Fusion of intratumoural- and peritumoural-based predictive models improves the prediction of breast cancer subtypes.

Indexed as

AdultAgedAged, 80 and overBiopsyBreast NeoplasmsFemaleHumansMagnetic Resonance ImagingMiddle AgedNeoplasm StagingPredictive Value of TestsROC CurveBreast neoplasmsDiagnostic imagingMagnetic resonance imaging

Identifiers

PMID30617495
OpenAlexW2910630672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.